Plasmablastic transformation of multiple myeloma

Human Pathology

Volumn 34, Issue 7, 2003, Pages 710-714

  Lee, Cheuk Kwong ^b   Ma, Edmond S K ^a   Shek, Tony W H ^b   Lam, Clarence C K ^b   Au, Wing Yan ^b   Wan, Thomas S K ^b   Chan, Li Chong ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

Cytogenetics; Fluorescence in situ hybridization; Immunophenotype; Plasmablastic myeloma; Ultrastructure

Indexed keywords

ACUTE LEUKEMIA; AGED; ARTICLE; BLAST TRANSFORMATION; BONE MARROW CELL; CANCER SURVIVAL; CASE REPORT; CELL ULTRASTRUCTURE; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOPHENOTYPING; MALE; MALIGNANT TRANSFORMATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL;

EID: 0037707202     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00181-3     Document Type: Article

References (15)

1. Bartl R, Frisch B, Burkhardt R, et al: Bone marrow histology in myeloma: Its importance in diagnosis, prognosis, classification and staging. Br J Haematol 51:361-375, 1982
2. Greipp PR, Raymond NM, Kyle RA, et al: Multiple myeloma: Significance of plasmablastic subtype in morphological classification. Blood 65:305-310, 1985
3. Carter A, Hocherman I, Linn S, et al: Prognostic significance of plasma cell morphology in multiple myeloma. Cancer 60:1060-1065, 1987
4. Duire BG, Grogan TM: CALLA-positive meyloma: An aggressive subtype with poor survival. Blood 66:229-232, 1985
5. Tamura J, Kurabayashi H, Sawamura M, et al: Clinical features of common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma: Report of four cases. Blut 58:229-233, 1989
6. Falini B, De Solas I, Levine AM, et al: Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: A clinicopathologic study of 10 cases. Blood 59:923-933, 1982
7. Foucar K, Raber M, Foucar E, et al: Anaplastic myeloma with massive extramedullary involvement. Report of two cases. Cancer 51:166-174, 1983
8. Allen SL, Coleman M: Aggressive phase multiple myeloma: A terminal anaplastic transformation resembling high-grade lymphoma. Cancer Invest 8:417-424, 1990
9. Grogan TM, Durie BG, Lomen C, et al: Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture and kinetic features. Blood 70:932-942, 1987
10. Epstein J, Barlogie B, Katzmann J, et al: Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood 71:861-865, 1988
11. Grogan TM, Durie BG, Spier CM, et al: Myelomonocytic antigen positive multiple myeloma. Blood 73:763-769, 1989
12. Ma SK, Wan TSK, Cheuk ATC, et al: Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/ AML1 gene fusion: A molecular cytogenetics study. Leukemia 15:1442-1447, 2001
13. Piccinini L, Artusi T, Bonacorsi G, et al: Acute leukemia of plasmablastic type as terminal phase of multiple myeloma. Haematologica 87:E1M04, 2002
14. Epstein J, Xiao HQ, He XY: Markers of multiple hematopoietic-cell lineages in multiple myeloma. N Engl J Med 322:664-668, 1990
15. Lai JL, Zandecki M, Mary JY, et al: Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490-2497, 1995